Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
8-K
Debt Issuance
confidence 85%
filed 2026-08-12
Item 1.01
Blue Water Acquisition Corp. III issued an amended and restated convertible unsecured promissory note in the aggregate principal amount of $750,000 to its sponsor on August 11, 2026, documenting an additional $250,000 advance for working capital. The note is convertible into up to 75,000 New Units (each comprising one Class A ordinary share and one-half warrant), representing both a material debt obligation and a dilutive equity issuance.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-08-12
Item 2.02
Journey Medical issued a press release on August 12, 2026, announcing financial results for the three months ended June 30, 2026 (Q2 2026). The disclosure includes total revenues of $18.5 million (23% growth year-over-year), Emrosi® revenues of $8.1 million, gross margin of 67%, narrowed net loss of $0.3 million, and cash position of $25.6 million. This is a standard quarterly earnings release with consolidated financial statements and operational metrics, clearly falling under Item 2.02 Results of Operations and Financial Condition.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 95%
filed 2026-08-12
Item 1.01
CCO Holdings issued approximately $3.3 billion in aggregate principal amount of Senior Secured Notes in two tranches (7.087% due 2038 and 7.337% due 2041) in connection with an early settlement of exchange offers on August 12, 2026, creating direct financial obligations governed by a supplemental indenture and registration rights agreement.
View raw filing on EDGAR →
8-K
M&A activity
confidence 97%
filed 2026-08-12
Item 2.01
Modiv Industrial completed a merger with a subsidiary of GNL, resulting in a change of control. Modiv shareholders received 1.975 shares of GNL common stock per share of Modiv Class C common stock, and preferred shareholders received $25.00 per share in cash. The company ceased separate existence and its common and preferred stock were suspended from NYSE trading effective on the Closing Date.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 65%
filed 2026-08-12
Item 1.02
The KeyBank Credit Agreement from January 2022 was terminated with full repayment of all outstanding amounts and release of security interests as of the Closing Date, in connection with the merger completion.
View raw filing on EDGAR →
8-K
Governance Other
confidence 75%
filed 2026-08-12
Item 5.03
The company's certificate of formation and operating agreement were amended automatically by operation of law upon the effective time of the merger, substituting the governing documents of the merged entity.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-08-12
Item 2.02
This is a clear earnings release disclosing Q2 2026 financial results for Knightscope. The press release reports record revenue of $9.0 million (up 228% YoY), positive gross margin of $0.7 million (vs. prior-year gross loss), and net loss of $14.1 million. The disclosure includes detailed financial highlights, operational metrics, and forward guidance, which are material to investors assessing the company's financial performance and trajectory.
View raw filing on EDGAR →
8-K
M&A activity
confidence 92%
filed 2026-08-12
Item 1.01
ArriVent entered into an exclusive, sublicensable license agreement with Shanghai Allist Pharmaceuticals on August 11, 2026, granting Allist rights to develop and commercialize ARR-002 in Greater China, with up to $80.6 million in potential payments and a joint global development collaboration committee.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-08-12
Item 2.02
ArriVent disclosed Q2 2026 financial results (ended June 30, 2026) via press release on August 12, 2026, reporting a net loss of $93.2 million for the six-month period, cash and investments of $373.1 million, and cash runway extending into 2028.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 85%
filed 2026-08-12
Item 8.01
Lucid registered for resale approximately 75.7 million shares of Class A Common Stock (51.7 million from conversion of Series C Convertible Preferred Stock and 24.0 million issued to SMB/Uber subsidiary) plus 55,000 shares of Series C Convertible Preferred Stock. Although the filing emphasizes "no new shares will be issued," the registration of these previously-issued private placement shares for resale creates material dilution risk to existing shareholders. The involvement of major investors (Saudi Arabia's Public Investment Fund via Ayar and Uber Technologies via SMB) and the substantial share count make this a material capital event affecting shareholder value.
View raw filing on EDGAR →
6-K
M&A activity
confidence 92%
filed 2026-08-12
EX-99.1
This exhibit is a Contingent Value Rights (CVR) Agreement executed by Agnico Eagle Mines Limited and Computershare Trust Company of Canada, dated June 16, 2026, in connection with an arrangement agreement with Rupert Resources Ltd. dated April 17, 2026. The agreement establishes the issuance of up to 207,654,166 CVRs entitling holders to receive up to $3.00 per right upon satisfaction of specified payment conditions tied to gold mineral reserves and commercial production milestones on the acquired property. This is a material acquisition-related instrument documenting contingent consideration in an M&A transaction.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-08-12
Item 2.02
This is a clear earnings release disclosing Lulu's Fashion Lounge's second quarter 2026 financial results for the period ended June 28, 2026, including net revenue of $67.8 million, net loss of $1.5 million, and Adjusted EBITDA of $1.0 million, along with reaffirmed full-year fiscal 2026 guidance. The press release is attached as Exhibit 99.1 and contains detailed financial statements and management commentary on operational performance.
View raw filing on EDGAR →
8-K
Earnings release
confidence 97%
filed 2026-08-12
Item 2.02
MaxCyte issued a press release on August 12, 2026 announcing its financial results for the quarter ended June 30, 2026, disclosing total revenue of $7.3 million, net loss of $8.9 million, and full-year 2026 guidance of $30–$32 million in revenue. The release includes unaudited condensed consolidated financial statements and management commentary on strategic developments including the Genentech partnership and SPL portfolio progress.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 95%
filed 2026-08-12
Item 2.02
The filing discloses a quarterly distribution of $0.001 per unit to be paid on or before August 31, 2026, to unitholders of record as of August 24, 2026. This is a routine but material dividend/distribution announcement for a trust that regularly distributes proceeds from natural gas royalty interests. The press release explicitly announces the quarterly distribution amount and payment details, which is the core substance of Item 2.02 disclosure.
View raw filing on EDGAR →
8-K
Exec departure
confidence 95%
filed 2026-08-12
Item 5.02
Mr. Patrick Bombach resigned from Mobileye's board of directors effective immediately on August 8, 2026, in connection with his resignation from Intel Corporation (the controlling shareholder). This is a clear departure of a director. While the filing notes the resignation was not due to disagreement, the departure of a board member at a public company is material to investors assessing governance and board composition.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-08-12
Item 2.02
This is a standard earnings release disclosing Armata's financial results for Q2 2026 and six months ended June 30, 2026, furnished as Exhibit 99.1 under Item 2.02. The press release includes detailed financial statements (balance sheet, income statement), operational metrics, and clinical/regulatory milestones. The company reported Q2 net income of $74.1 million (driven by a $91.0 million non-cash gain on the Convertible Loan), increased cash position to $24.0 million, and significant progress on its AP-SA02 Phase 3 program including FDA Fast Track designation and pediatric study plan agreement.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-08-12
Item 2.02
This is a clear earnings release disclosing Energous Corporation's financial results for Q2 2026 and the six-month period ended June 30, 2026. The filing explicitly states "On August 12, 2026, Energous Corporation issued a press release announcing its financial results for the three and six months ended June 30, 2026" and furnishes the press release as Exhibit 99.1. The disclosure includes revenue ($3.1M for Q2, $6.2M for six months), gross profit, operating expenses, net loss, and per-share metrics, along with balance sheet and cash position data. The results show significant growth (217% revenue improvement YoY for Q2, 368% for six months) and represent a material milestone for the company, making this disclosure material to investors.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 92%
filed 2026-08-12
Item 1.01
Ryman Hospitality Properties entered into an underwriting agreement on August 10, 2026, to issue 5,100,000 shares of common stock at $117.00 per share in a registered public offering, with underwriters exercising a 30-day option for an additional 765,000 shares on August 11, 2026. The offering closed on August 12, 2026, generating approximately $658 million in net proceeds. This is a material registered equity issuance that dilutes existing shareholders and represents a significant capital-raising event.
View raw filing on EDGAR →
6-K
Shareholder vote
confidence 95%
filed 2026-08-12
The 6-K discloses the results of an extraordinary general meeting held on August 11, 2026, where shareholders voted on seven proposals. All proposals were approved, including a company name change from "BIT ORIGIN LTD" to "SANGRIX INC.", a massive share capital increase (from US$15,000 to US$60,000,000), a 5-for-1 share consolidation, and amendments to the memorandum of association. These are material governance and capital structure changes that would affect a reasonable investor's assessment of the registrant.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 97%
filed 2026-08-12
Item 5.07
AvalonBay stockholders approved three proposals at a Special Meeting held on August 12, 2026: (1) approval of the merger with Equity Residential (126.5M for, 51.7K against); (2) approval of merger-related compensation (125.6M for, 938.9K against); and (3) adjournment of the meeting (116.0M for, 10.5M against). All three proposals passed with overwhelming support, representing approximately 90% of outstanding shares voting in favor of the transformative merger that will create "Vivmark Residential," expected to close on August 17, 2026.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-08-12
Item 2.02
Battalion Oil Corporation disclosed its second quarter 2026 financial results, including quarterly operating revenues of $48.1 million, net income of $9.1 million ($0.34 per share), production volumes of 12,407 Boe/d, and adjusted EBITDA of $12.3 million, along with balance sheet and liquidity metrics as of June 30, 2026.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 25%
filed 2026-08-12
Item 1.01
This disclosure describes the closing of a registered underwritten public offering of 18.4 million shares of Class A-1 common stock and entry into an Underwriting Agreement. While the Item 1.01 caption suggests a material agreement, the substance is an equity issuance (common stock offering), not a debt issuance. However, no specific "equity_issuance" category exists in the taxonomy; the closest financial category is debt_issuance, though this is a poor fit. This may be better classified as dilutive_issuance (unregistered equity sale) or financial_other, but the offering appears to be registered under Form S-11, not a private placement. The event is material to investors but does not fit cleanly into the provided taxonomy.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-08-12
Item 2.02
Park Dental Partners issued a press release on August 12, 2026 announcing its second quarter 2026 financial results for the period ended June 30, 2026. The disclosure includes detailed financial statements, revenue growth of 5.1% to $66.2 million, net income of $1.3 million, and updated full-year 2026 guidance. This is a standard quarterly earnings release filed under Item 2.02 with the press release furnished as Exhibit 99.1.
View raw filing on EDGAR →
8-K
Governance Other
confidence 75%
filed 2026-08-12
The filing discloses that Matthew J. Reintjes, the President and CEO, was appointed to the additional position of Chair of the Board effective August 7, 2026, while Robert K. Shearer transitioned from independent Chair to Lead Independent Director. This is a governance restructuring involving a change in board leadership and chair role, but does not fit the specific categories of exec_appointment (which typically applies to new hires or promotions to officer roles) or exec_departure (no one left). The event is material as it affects board structure and independence, but is best classified as a governance matter outside the named categories.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-08-12
Item 2.02
GMR Solutions Inc. issued a press release on August 12, 2026, announcing financial results for the three and six months ended June 30, 2026, including net revenue of $1,490.3 million (Q2 2026) and net loss of $28.3 million, along with reaffirmed full-year 2026 guidance. This is a standard earnings release disclosure under Item 2.02, furnished as Exhibit 99.1, and is material to investors assessing the company's operational and financial performance.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 85%
filed 2026-08-12
Item 5.02
The filing discloses the appointment of Jeffrey F. DiModica to the Board of Directors effective August 10, 2026, and his appointment to the Investment Committee. While the section also mentions Jeffrey G. Dishner's resignation, the principal disclosed action centers on DiModica's appointment to the Board. DiModica's extensive background as President since 2014 and his prior directorship (2009–2014) make this a material governance event affecting board composition and oversight.
View raw filing on EDGAR →
6-K
Earnings release
confidence 95%
filed 2026-08-12
EX-99.1
This exhibit is a press release announcing Belite Bio's unaudited second quarter 2026 financial results, including detailed income statements, balance sheet data, and operating metrics. The document explicitly states "Belite Bio Reports Unaudited Second Quarter 2026 Financial Results" and includes comprehensive financial tables showing net loss of $28.4 million for Q2 2026 and $55.4 million for the six-month period. This is a discrete earnings announcement, not a periodic financial report filing, and is material as it discloses significant operating losses and cash burn relevant to investor assessment.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 95%
filed 2026-08-12
Item 1.01
Star Mountain Lower Middle-Market Capital Corp entered into a Note Purchase Agreement on August 6, 2026, to issue $25,000,000 in aggregate principal amount of Floating Rate Senior Unsecured Notes due January 15, 2029. This represents a material creation of a new direct financial obligation through private placement debt issuance.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 97%
filed 2026-08-12
Item 5.07
Equity Residential shareholders voted on August 12, 2026 to approve three proposals related to the proposed merger of equals with AvalonBay Communities, including share issuance, charter amendment, and adjournment. All three proposals were approved with overwhelming majorities (>99% of votes cast), representing approximately 90% of outstanding shares, with the combined entity expected to be named Vivmark Residential and close on August 17, 2026.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 98%
filed 2026-08-12
Item 8.01
The filing discloses the Board of Directors' declaration of a quarterly cash dividend of $5.60 per share, representing a 4.7% increase from the prior quarter. This is a material dividend distribution event, particularly notable as it marks the 61st consecutive year of dividend increases and reinforces the company's "Dividend King" status. The announcement includes record financial performance and strong capital ratios supporting the increase.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-08-12
Item 2.02
Comscore issued a press release on August 12, 2026 announcing its financial results for the quarter ended June 30, 2026, disclosing Q2 2026 revenue of $79.2 million (down 11.3% YoY), net loss of $14.8 million, and adjusted EBITDA of $1.3 million. The filing explicitly states this is Item 2.02 (Results of Operations and Financial Condition) with the press release furnished as Exhibit 99.1, which is the standard format for earnings releases. The disclosure includes detailed financial metrics, segment performance, balance sheet information, and full-year 2026 guidance, all hallmarks of a quarterly earnings announcement.
View raw filing on EDGAR →
8-K
Operational Other
confidence 75%
filed 2026-08-12
Item 8.01
CTT Pharmaceutical received a continuation-in-part (CIP) patent approval from the U.S. Patent Office for its micelle delivery technology covering nicotine, vitamins, and caffeine applications (effective August 11, 2026). This is a material operational/strategic event—patent protection strengthens the company's competitive position and enables commercialization of multiple product forms (strips, gum, pouches, lozenges, tablets). While not a named event type, it is clearly operational and strategic in nature, making it an operational_other classification rather than a routine administrative disclosure.
View raw filing on EDGAR →
6-K
Shareholder vote
confidence 95%
filed 2026-08-12
EX-99.1
This exhibit discloses the results of Himax's annual general meeting held on August 12, 2026, including shareholder adoption of 2025 audited financial statements and re-election of an independent director. The disclosure of shareholder vote outcomes at an annual meeting is a classic shareholder_vote_results event. The approval of audited financial statements and director re-election are material governance matters affecting investor assessment of the company's financial reporting and board composition.
View raw filing on EDGAR →
6-K
Earnings release
confidence 95%
filed 2026-08-12
EX-99.1
This is a press release disclosing Q2 2026 financial results for Titan Mining Corp, reporting record quarterly revenue of $25.7 million (up 57% year-over-year), net income of $5.4 million, and Adjusted EBITDA of $9.6 million (up 272% year-over-year). The document includes detailed operating metrics, financial tables, and forward guidance, which are hallmarks of an earnings release. Material to investors assessing the registrant's financial performance and operational trajectory.
View raw filing on EDGAR →
6-K
Earnings release
confidence 98%
filed 2026-08-12
EX-99.1
This is a press release disclosing BrainsWay's Q2 2026 financial results, including revenue of $17.1 million (35% YoY growth), adjusted EBITDA of $3.5 million (141% YoY growth), and net income of $2.7 million. The company also raised full-year 2026 revenue and EBITDA guidance. The exhibit includes consolidated financial statements (balance sheet, income statement, cash flows) and reconciliation of non-IFRS measures, all hallmarks of a quarterly earnings release. Material to investors assessing operational performance and growth trajectory.
View raw filing on EDGAR →
6-K
Exec appointment
confidence 75%
filed 2026-08-12
EX-99.3
The exhibit announces the appointment of Peter Rawlins as Chief Financial Officer effective August 26, 2026, replacing interim CFO David Allen. While the exhibit also reports Q2 2026 financial results, the principal disclosed action is the executive appointment. The CFO role is material to a development-stage company executing a major refinery construction project, and Rawlins' extensive mining finance and capital markets experience is directly relevant to the company's funding and project execution priorities.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-08-12
Item 2.02
The filing discloses Arbutus Biopharma's second quarter 2026 financial results via a press release dated August 12, 2026, including revenue of $1.0 million, net loss of $5.1 million ($0.03 per share), and cash position of $92.6 million. This is a standard quarterly earnings release filed under Item 2.02 with financial statements and operational metrics, making it a material disclosure affecting investor assessment of the company's financial condition.
View raw filing on EDGAR →
6-K
Operational Other
confidence 75%
filed 2026-08-12
EX-99.1
This is an investor presentation deck disclosing BrainsWay's Q2 2026 financial performance, strategic platform evolution, and growth initiatives. The exhibit reports record system shipments (+42% YoY), revenue growth (+35%), gross margin expansion (75%), and profitability metrics (Adj. EBITDA +141%, Operating Income +281%, Net Income +60%), alongside strategic announcements of clinic network expansion, home therapy investment (Neurolief $11M convertible), and international scaling. While the presentation contains financial results, it is structured as a strategic business update and investor communication rather than a formal earnings release or periodic financial report. The disclosure is material as it communicates significant operational momentum, margin expansion, and strategic capital deployment that would affect a reasonable investor's assessment of the company's growth trajectory and execution.
View raw filing on EDGAR →
6-K
Earnings release
confidence 98%
filed 2026-08-12
EX-99.1
This is a press release announcing Stantec's Q2 2026 financial results, disclosing net revenue of $1.8 billion (up 11.5% YoY), adjusted EBITDA of $332.9 million (up 17.1%), and adjusted EPS of $1.61 (up 18.4%). The release also includes updated 2026 guidance with refined adjusted EBITDA margin targets and organic growth expectations. As a quarterly earnings announcement with detailed financial metrics and forward guidance, this is a classic earnings_release event that would materially affect a reasonable investor's assessment of the company's financial performance and outlook.
View raw filing on EDGAR →
6-K
Earnings release
confidence 98%
filed 2026-08-12
EX-99.1
This is a press release announcing CAE's first quarter fiscal 2027 financial results, disclosing revenue of $1,173.4 million (up 6.8% YoY), EPS of $0.10 vs. $0.18 prior year, adjusted EPS of $0.26 (flat YoY), and free cash flow of $104.0 million. The document includes consolidated results, segment performance (Civil and Defense), cash flow metrics, and fiscal 2027 outlook. This is a discrete earnings announcement, not a periodic financial report filing.
View raw filing on EDGAR →
6-K
Earnings release
confidence 98%
filed 2026-08-12
EX-99.1
This is a press release announcing Allot Ltd.'s unaudited financial results for the second quarter of 2026, including revenue of $27.7 million (up 15% YoY), GAAP operating income of $1.1 million, and a raised full-year 2026 revenue guidance to $115–$118 million. The document contains consolidated balance sheets, statements of operations, cash flows, and GAAP-to-non-GAAP reconciliations typical of a quarterly earnings announcement. Material to investors as it discloses quarterly financial performance and updated forward guidance.
View raw filing on EDGAR →
6-K
Earnings release
confidence 98%
filed 2026-08-12
EX-99.1
This exhibit is a press release announcing Ituran's second quarter 2026 financial results, with record revenue of $104.8 million (up 21% YoY), net income of $17.3 million (up 29% YoY), and EBITDA of $28.5 million (up 24% YoY). The document includes condensed consolidated financial statements (balance sheet, income statement, and cash flow statement) as of and for the periods ended June 30, 2026. This is a discrete earnings announcement, not a periodic financial report filing, and the results are material to investors assessing the registrant's financial performance and growth trajectory.
View raw filing on EDGAR →
6-K
Earnings release
confidence 98%
filed 2026-08-12
EX-99.1
This is a press release announcing Global-e's Q2 2026 financial results, including GMV of $2,089 million (44% YoY growth), revenue of $299.0 million (39% YoY growth), and Adjusted EBITDA of $62.4 million (62% YoY growth). The company also raised full-year 2026 guidance across all metrics. The disclosure includes detailed financial metrics, business highlights, and forward-looking guidance typical of a quarterly earnings release.
View raw filing on EDGAR →
6-K
Dividend Distribution
confidence 98%
filed 2026-08-12
EX-99.1
The exhibit is a press release announcing Board approval of a cash dividend distribution of $0.50 per share totaling approximately $10 million to be paid on October 14, 2026. This is a straightforward dividend declaration meeting the definition of `dividend_distribution`. The materiality is clear: a $10 million cash return to shareholders represents a material capital allocation decision that would affect a reasonable investor's assessment of the company's capital strategy and financial position.
View raw filing on EDGAR →
6-K
Earnings release
confidence 98%
filed 2026-08-12
EX-99.1
This is a press release announcing Nexxen's Q2 2026 financial results, including record Contribution ex-TAC of $97.8 million (up 11% YoY), record programmatic revenue of $95.2 million (up 12% YoY), and all-time record quarterly CTV revenue of $37.8 million (up 33% YoY). The company also raised full-year 2026 guidance for the third time. The disclosure includes detailed financial highlights, operational metrics, and forward-looking guidance typical of an earnings release, making it material to investors' assessment of the company's financial performance and trajectory.
View raw filing on EDGAR →
6-K
Delisting risk
confidence 95%
filed 2026-08-12
EX-99.1
The exhibit discloses that AGM Group Holdings received a Nasdaq non-compliance notice on May 18, 2026, for failure to timely file its Form 20-F annual report, triggering Nasdaq Listing Rule 5250(c)(1) violation and delisting risk. The company subsequently filed the Form 20-F on August 7, 2026, and Nasdaq confirmed regained compliance on August 11, 2026. This is a material delisting-risk disclosure because it documents the company's prior non-compliance with continued listing standards and the remedial action taken to cure the violation.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-08-12
Item 1.01
OLB Group entered into an Equity Distribution Agreement with Maxim Group LLC on August 7, 2026, establishing an "at-the-market offering" (ATM) program to sell up to $1,600,000 of common stock shares. This is a classic dilutive equity issuance under Rule 415, where the company retains discretion over timing and volume but commits to a registered offering program that will dilute existing shareholders. The prospectus supplement filed on August 7, 2026, registered the shares for sale, making this a material capital-raising event typical of small- and mid-cap issuers.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 95%
filed 2026-08-12
Item 8.01
Blue Owl Finance LLC, an indirect subsidiary of Blue Owl Capital Inc., issued and priced $750,000,000 of 6.750% Senior Notes due 2036, fully guaranteed by the Company and multiple subsidiaries. This is a material creation of a direct financial obligation disclosed under Item 8.01 (Other Events), with the company intending to use net proceeds to repay existing revolving credit facility borrowings. The size, terms, and guarantor structure make this a significant debt issuance material to investors.
View raw filing on EDGAR →
8-K
Going Concern
confidence 95%
filed 2026-08-12
Item 8.01
The auditor's report explicitly states "substantial doubt about the Company's ability to continue as a going concern" because the Company "has less than one year remaining in its life and there can be no assurance a successful business combination will occur within that time." This is the unmistakable language of a going-concern disclosure, a material event that would affect a reasonable investor's assessment of the registrant's viability.
View raw filing on EDGAR →
6-K
Delisting risk
confidence 92%
filed 2026-08-12
EX-99.1
The announcement discloses NOVONIX's failure to comply with Nasdaq's minimum bid price requirement (closing bid below US$1.00 for 30 consecutive business days as of 18 March 2026) and the Company's 180-day compliance period to regain compliance. The ADS ratio change from 1:4 to 1:40 is explicitly stated as intended to increase per-ADS trading price and assist in regaining compliance, directly addressing delisting risk. This is a material disclosure of a continued listing rule violation and the Company's remedial action.
View raw filing on EDGAR →